Latest Close
₹3,459.70
+3.16%
Connecting…
Day Range
-
Full OHLC pending
Volume
-
Full session data pending
50 DMA
₹3,535.31
200 DMA
₹3,113.59
1 year gain / loss
+₹991.10(+40.15%)
₹2,468.60 → ₹3,459.70· 2025-10-30 to 2026-10-30
Charting by TradingView
This stock does not satisfy the default swing-support rules at the selected chart endpoint. Its price, volume and moving averages remain available for manual research.
Snapshot 2026-10-31 · Financial period Sep 2026 · Consolidated figures where available
Ajanta Pharma Limited is an India-based specialty pharmaceutical company. It provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. It is focused on branded generic businesses across India, Asia, and Africa. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.
Market Cap
₹43,890.61 Cr
P/E
34.76×
Sector -38.72× · above
P/B
9.03×
Sector 4.11× · above
EV / EBITDA
23.34×
Sector 22.21× · above
ROE
25.99%
Sector 0.31%
ROCE
33.90%
Sector 6.48%
ROA
19.65%
Sector -17.12%
Cash Flow / Profit
0.50×
| Period | Revenue | Operating profit | Net profit |
|---|---|---|---|
| Sep 2026 | 1,831.55 +7.9% | 535.15 | 388.14 +16.1% |
| Jun 2026 | 1,696.86 +14.4% | 446.8 | 334.22 +25.3% |
| Mar 2026 | 1,483.07 +6.0% | 347.11 | 266.7 -2.6% |
| Dec 2025 | 1,399.81 | 358.6 | 273.77 |
Dividend
05 Aug 2026 · ₹32
Dividend
10 Nov 2025 · ₹28